Connect with us

COVID-19

‘Incompetence’: Pentagon Doesn’t Know How Much Money It Sent To Chinese Entities For Risky Virus Research

Published

1 year ago

6 minute read

From the Daily Caller News Foundation

By NICK POPE

 

The Department of Defense (DOD) does not know how much money it directly or indirectly sent to Chinese entities to conduct research on viruses with pandemic potential, according to a new report by the DOD’s Office of Inspector General (OIG).

The OIG’s report found that DOD has supplied Chinese entities — whether directly or indirectly via subgrants — with taxpayer cash to research pathogens and the enhancement thereof, but the exact figure is unknown because of “limitations” in the DOD’s internal tracking system. Government funding for such research in China has come under scrutiny since the coronavirus pandemic, which multiple government entities believe started when an engineered virus leaked from a Chinese laboratory that was hosting U.S. government-backed gain-of-function research.

“Incompetence, absurdity, insanity; it’s hard to find a word that adequately describes this. Of all the things that DOD tracks, funds for dangerous research that could find their way to a hostile regime should be at the top of the list of those they keep close tabs on,” Michael Chamberlain, director of Protect the Public’s Trust, told the Daily Caller News Foundation regarding the OIG report’s findings. “It makes you wonder if they really know where all our nuclear warheads are. The military is one of the few areas of government in which the public still maintains a modicum of trust, but, sadly, it looks like they are working hard to squander even that.”

The OIG review of this specific issue was required by the terms of the National Defense Authorization Act (NDAA) for fiscal year 2024, which President Joe Biden signed into law in December 2023. The OIG’s investigation sought to determine just how much taxpayer cash was routed via “grants, contracts, subgrants, subcontracts, or any other type of agreement or collaboration, to Chinese research labs or to fund research or experiments in China or other foreign countries that could have reasonably resulted in the enhancement of pathogens of pandemic potential, from 2014 through 2023.”

Specifically, the OIG learned from U.S. Army officials that 12 grant awards fit the description of what it was investigating, seven of which were subgrants or subcontracts provided to entities in China or other foreign countries for research involving or related to enhanced pathogens, its report states. The OIG’s review also identified a further $9.9 million in funding that reached Chinese entities for research purposes, though that research was unrelated to pathogens.

“However, we did encounter significant challenges in searching for awards related to section 252 of the FY 2024 NDAA reporting requirement due to limitations in the DoD’s systems used to track contracts and grants,” the OIG report states. “Therefore, the full extent of DoD funds provided to Chinese research laboratories or other foreign countries for research related to enhancement of pathogens of pandemic potential is unknown.”

The issues with DOD’s grant tracking systems created “significant constraints” for OIG that “hindered [its] ability to conduct a thorough examination” of DOD’s involvement in funding this specific type of research, the report states.

The Government Accountability Office (GAO) previously conducted a similar review of DOD’s spending and Chinese entities receiving taxpayer dollars to conduct research on pathogens of pandemic potential, and its final report — published in September 2022 — also detailed similar struggles with the DoD’s grant and sub-grant tracking systems.

The Department of Energy (DOE) has concluded that the COVID-19 pandemic most likely began when the virus leaked from the Wuhan Institute of Virology in China, which was the site of gain-of-function research funded by the U.S. government via an organization called EcoHealth Alliance. Additionally, Federal Bureau of Investigation (FBI) Director Christopher Wray has acknowledged that his organization has reached a similar conclusion.

Despite this, former Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci has reiterated his position that a lab leak is the less likely scenario of the two as recently as Tuesday. The COVID-19 pandemic killed more than one million Americans, according to the Centers for Disease Control and Prevention (CDC), and millions more globally, while the American policy response to the pandemic inflicted considerable economic and social damage on the general public.

The DOD did not respond immediately to a request for comment.

Related Topics:

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

More from this author
Food / 2 hours ago

Trump says Coca-Cola will switch to real cane sugar in U.S.

COVID-19 / 2 hours ago

WATCH: Big Pharma scientist admits COVID shot not ‘safe and effective’ to O’Keefe journalist

COVID-19 / 2 hours ago

Japan disposes $1.6 billion worth of COVID drugs nobody used

COVID-19

WATCH: Big Pharma scientist admits COVID shot not ‘safe and effective’ to O’Keefe journalist

Published on July 17, 2025

By

From LifeSiteNews

By Doug Mainwaring

‘None of that stuff was safe and effective. We didn’t do the typical tests,’ Joshua Rys of Johnson & Johnson said to one of James O’Keefe’s undercover journalists.

A lead scientist for a global pharmaceutical firm disclosed on hidden camera that his firm’s COVID-19 vaccine underwent rushed testing, lacked research, and admitted that, in direct contradiction to the Biden administration’s constant refrain, the drug was not “safe and effective.”

“None of that stuff was safe and effective. We didn’t do the typical tests,” said Joshua Rys, a lead regulatory affairs scientist for Johnson & Johnson (J&J), not realizing that he was being filmed by one of James O’Keefe’s undercover journalists.

Rys explained that normally a new drug undergoes an extended period of testing, including human trials, but the COVID-19 vaccine circumvented those safety measures in order to rush the product to the public.

“This was just, ‘Let’s test it on some lab-rat models, analyze and see if it works,” said Rys, “and just throw it to the wind and see what happens.”

“I’m sure somebody is going to get sued for that stuff, eventually,” he predicted.

“Do you have any idea [of] the lack of research that was done on those products?” asked the J&J lead scientist.

“People wanted it. We gave it to them,” said Rys.

O’Keefe later approached Rys to ask what led him to tell a total stranger that his product was not safe and effective, but Rys evaded O’Keefe and his probing. 

O’Keefe explained that the work of his O’Keefe Media Group (OMG) undercover journalists is crucial because, he claimed, up to 80 percent of the revenue cable and other news organizations derive from ads comes from Big Pharma.

Continue Reading

COVID-19

Japan disposes $1.6 billion worth of COVID drugs nobody used

Published on July 17, 2025

By

From LifeSiteNews

By Calvin Freiburger

The nation’s health ministry has already trashed 2 million doses of PaxlovidPACK and Lagevrio, and will dispose of 1.77 million doses of Xocova by the end of February 2026.

Japan is disposing of $1.6 billion worth of COVID-19 drugs that went unused and are now expired in a dramatic disconnect between government projections and reality.

The Japanese Broadcasting Corporation reported that the nation’s health ministry has already trashed 1.75 million patients’ worth of PaxlovidPACK and 780,000 patients’ worth of Lagevrio doses, and will dispose of 1.77 million patients’ worth of Xocova by the end of February 2026.

The government had been required by law to purchase enough oral COVID drugs for 5.6 million people, to be distributed free of charge through May 2023, at which point the virus was downgraded to the same threat level as normal seasonal influenza. But 2.5 million, a little under half the supply, remained unused by the time they hit their expiration dates.

The Star added that the value of the destroyed drugs is estimated to be roughly 240 billion yen, or 1.6 billion US dollars.

Across the world, governments took drastic action to counter the COVID pandemic, based in large part on exaggerated assumptions about the virus’s transmissibility and threat to non-elderly individuals without comorbidities. A large body of evidence has found that mass restrictions on personal and economic activity undertaken in 2020 and part of 2021 caused far more harm than good in terms of personal freedom and economics as well as public health, and that lives could have been saved through far less burdensome methods, such as the promotion of established therapeutic drugs, narrower protections focused on those most at risk (such as the elderly and infirm), and increasing vitamin D intake.

In Florida, the first report by a grand jury impaneled by Republican Gov. Ron DeSantis determined that lockdowns did more harm than good, that masks were ineffective at stopping COVID transmission, that COVID was “statistically almost harmless” to children and most adults, and that it is “highly likely” that COVID hospitalization numbers were inflated.

Much like the controversial COVID vaccines, concerns were raised about the safety and effectiveness of COVID therapeutics such as Paxlovid and Lagevrio as well.

In May, former Japanese minister of internal affairs and communications Kazuhiro Haraguchi announced he had cancer, and said testing of the lesions linked it to spike proteins from the COVID-19 vaccine he had received two years before.

Continue Reading

Trending

X